Colossal Joins Ranks Of SpaceX, OpenAI With $10.2 Billion Valuation

In a world where the next big breakthrough often feels a little too far-fetched, Colossal Biosciences is making headlines by achieving something straight out of science fiction.

The world's first de-extinction company has just secured a hefty $200 million in Series C funding. The funding, effectively, pushes its valuation to a jaw-dropping $10.2 billion. With this, Colossal joins the ranks of elite "decacorns" like SpaceX, OpenAI, and Bolt—a company worth over $10 billion.

But this isn’t just another tech unicorn story.

Resurrecting The Past To Save The Future

Founded in 2021, Colossal's mission is to bring extinct species back to life. The latest round of funding is aimed at ramping up their efforts.

Think Jurassic Park, but without the moral dilemmas and, hopefully, fewer runaway dinosaurs. The infusion comes from TWG Global, a diversified holding company led by billionaire Mark Walter, who's no stranger to high-stakes ventures with his connections to the LA Dodgers and Chelsea FC.

Read Also: ‘The Dollar Will Remain Mighty’: Investors Double Down On Trump’s Economic Gambit

Pioneering Technologies For Biodiversity

What's really revolutionary here is Colossal's commitment to applying genetic engineering, not just to resurrect the past but to secure the future. The company uses biotechnology to develop software, wetware, and hardware solutions that could eventually combat the world's extinction crisis.

As species face unprecedented rates of extinction – 27,000 per year – Colossal is positioning itself as a key player in the race against time.

Funding To Accelerate Groundbreaking Science

The new funding will accelerate lab expansions, grow the team, and support a growing roster of species candidates for de-extinction. The company's toolkit of genetic technologies is already making advancements in ancient DNA and genomics. They’re laying the foundation for the resurrection of species like the woolly mammoth and the dodo (no, seriously).

Expanding Impact: Conservation And Human Health

Colossal doesn’t confine its efforts to just reviving species of old. The technology has the potential to advance conservation for endangered animals and even human health.

With a team of over 170 scientists, including geneticists from prestigious institutions like Harvard and MIT, Colossal isn't just dreaming big – it's attempting to make strides in science that could reshape biodiversity and ecosystems as we know them.

Read Next:

• Morgan Stanley’s Mike Wilson On Taking Risks – ‘The Real Money Is Made With Contrarian Views’

Photo: Gorodenkoff/Shutterstock.com